W1329 Patients With Mild-to-Moderate Ulcerative Colitis Experience Symptom Improvement 1 Week After Commencing Treatment With MMX® Mesalamine 2.4g/Day for Induction of Remission
Kane, Sunanda V., Solomon, Dory M., Palmen, Mary, Barrett, KarenVolume:
138
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(10)63220-9
Date:
May, 2010
File:
PDF, 62 KB
english, 2010